Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SurgiPure XD Reconstructive Tissue Matrix

K-Number: K152206 · 2016-03-08

Decision Date2016-03-08
Product CodeFTM
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

SurgiPure XD Reconstructive Tissue Matrix is the device name listed in this FDA 510(k) record. The listed applicant is Tissue Regenix Group Plc. It received FDA 510(k) clearance on 2016-03-08 under 510(k) number K152206. The device is classified under product code FTM. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SurgiPure XD Reconstructive Tissue Matrix?

SurgiPure XD Reconstructive Tissue Matrix is a medical device that received FDA 510(k) clearance on 2016-03-08. The listed applicant is Tissue Regenix Group Plc. The 510(k) number is K152206.

When did SurgiPure XD Reconstructive Tissue Matrix receive FDA 510(k) clearance?

SurgiPure XD Reconstructive Tissue Matrix received FDA 510(k) clearance on 2016-03-08, under 510(k) number K152206.

Who is the listed applicant for SurgiPure XD Reconstructive Tissue Matrix?

The FDA 510(k) record lists Tissue Regenix Group Plc as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SurgiPure XD Reconstructive Tissue Matrix?

The FDA product code for SurgiPure XD Reconstructive Tissue Matrix is FTM.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: FTM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.